Neurofilament light chain and glial fibrillary acidic protein level increases were associated with cognitive decline in T2D with obesity.
INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update Landmark exclusive option and license deal with Takeda for ACI-24.060 with $100 million upfront and additional ...
A molecule called glial fibrillary acidic protein (GFAP) rose significantly in the blood of patients who underwent high-intensity focused ultrasound (HIFU), a procedure that is used to treat tremors ...
Forty-eight hours after HIFU treatment, all the molecular markers except pTau-181 had risen significantly; however, GFAP rose the most, more than quadrupling on average compared to pre-treatment ...
We've identified the following companies as similar to Port of Tauranga Ltd ADR because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. P-tau 217 had high accuracy in diagnosing Alzheimer ...
Some scientists have long suspected that neuronal viruses such as herpes can hasten or even cause dementia. What about infections that don’t attack neurons directly? The COVID-19 pandemic offered ...
This may be due to poor preservation of cellular structures in frozen autopsy brain tissue. SERBP1 and pTau co-staining lacks an age matched non-AD control. Most quantifications of human IHC staining ...
Scientists measured levels of beta-amyloid (Aβ40, Aβ42), pTau-181, NfL, and glial fibrillary acidic protein (GFAP), which are all markers of Alzheimer’s disease. They also assessed the brain ...
Background Can plasma biomarkers as well as cerebrospinal fluid (CSF) perform in the separation of amyloid-beta-positive (Aβ+) vs amyloid-beta-negative (Aβ−) groups across an age range seen in an NHS ...